American pharmaceutical boss does not support tariffs on Australian medicines

26 March 2025 - The head of one of America's largest pharmaceutical companies says he does not support tariffs on ...

Read more →

Why US drug giants are so angry about Australia’s PBS

20 March 2025 - US pharmaceutical giants hope the protectionist Trump administration will force Australia to increase the price it pays ...

Read more →

Australia defends PBS as US companies urge Trump to impose reciprocal tariffs

19 March 2025 - American medical giants have labelled the federal government's PBS "egregious and discriminatory" and have pressed US ...

Read more →

Big pharma’s plea to Trump to punish Australia for cheaper medicines

19 March 2025 - American medical giants have slammed the $18 billion pharmaceutical benefits scheme in a plea to US ...

Read more →

Pharmaceutical reform agreement review report

6 March 2024 - The Department of Health and Aged Care has conducted a review of Pharmaceutical Reform Agreements (PRAs), to ...

Read more →

1 November 2022 updates as part of the digital transformation of Authority Required (Written) PBS listings

1 November 2022 - From 1 November 2022, the PBS listings for certain medicines will be updated as part of the ...

Read more →

Cheaper medicines legislation passed

27 October 2022 - The Australian Government’s legislation, which will see millions of Australians pay 29% less for scripts with the ...

Read more →

PBS minimum stockholding requirements

21 October 2022 - Amendments made by the National Health Amendment Act 2021 give effect to the commitments in the new ...

Read more →

2022 October price disclosure cycle – confirmed prices and patient savings reports

1 October 2022 - Combination flow-on reduction outcomes reflect confirmed 1 October 2022 prices on the Current Price Disclosure cycle web ...

Read more →

2022 October price disclosure cycle – patient savings

29 July 2022 - Indicative brand price reductions and patient savings resulting from the 2022 October Cycle of Price Disclosure have ...

Read more →

2022 October price disclosure cycle – indicative prices

4 July 2022 - Indicative 1 October 2022 prices resulting from the 2022 October Cycle of Price Disclosure have now been ...

Read more →

Price disclosure 2022 October cycle outcomes summary

24 June 2022 - The summary of price disclosure price reductions for the 2022 October Cycle has now been published on ...

Read more →

Updated price disclosure guidelines, price disclosure webpages and price disclosure dispute resolution process

8 June 2022 - Amendments made to the National Health Act 1953 and National Health (Pharmaceutical Benefits) Regulations 2017 by the ...

Read more →

Remake of National Health (Supply of Pharmaceutical Benefits – Under Co-payment Data and Claims for Payment) Rules 2022

25 May 2022 - The Department has recently remade the National Health (Claims and under co-payment data) Rules 2012, now ...

Read more →

Remake of the National Health (Pharmaceuticals and Vaccines – Cost Recovery) Regulations 2009

11 May 2022 - The Department has recently remade the National Health (Pharmaceutical and Vaccines—Cost Recovery) Regulations 2009 (2009 Regulations), ...

Read more →